By Associate Professor Suzanne Jean Hodgkinson

Conference Papers

Jokubaitis VG; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Haartsen J; Liew D; Butzkueven H, 2013, 'Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 55 - 56, presented at 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, DENMARK, Copenhagen, 02 October 2013 - 05 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000328751400086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cordato DJ; Thomas PR; Darshan G; Sanjeev T; Worthington JM; McDougall AJ; Hodgkinson SJ; Ibrahim HY; Griffith NC; Cappelen-Smith C; Beran RG, 2010, 'Decreasing Presentations of Seizures to Emergency Departments in a Large Australian Population', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, pp. A258 - A258, presented at 62nd Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 10 April 2010 - 17 April 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275274001259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

LINDSEY JW; HODGKINSON S; MEHTA R; ENZMANN D; SANDERS M; STEINMAN L, 1993, 'PHASE-I STUDY OF REPEATED TREATMENT WITH CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LIPPINCOTT-RAVEN PUBL, pp. A280 - A281, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KY35600489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

LINDSEY JW; HODGKINSON S; MEHTA R; SIEGEL RC; MITCHELL DJ; LIM M; PIERCY C; TRAM T; DORFMAN L; ENZMANN D; STEINMAN L, 1992, 'PHASE-1 CLINICAL-TRIAL OF CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LITTLE BROWN CO, CA, SAN DIEGO, pp. 413 - 419, presented at 44th Annual Meeting of the American-Academy-of-Neurology, CA, SAN DIEGO, http://dx.doi.org/10.1212/WNL.44.3_Part_1.413

Conference Proceedings (Editor of)

Wang CC; Li J; Tran GT; Hodgkinson SJ; Hall BM; Mccaughan GW; Allen R; Bishop GA, (eds.), 2005, 'Immunology and Cell Biology', Blackwell Publishing Asia, Carlton, Victoria, Australia, presented at 23rd Annual Scientific Meeting of the Transplantation Society of Australia and NZ, Canberra, 11 May 2005 - 13 May 2005

Conference Presentations

Husin H; Wallace J; Malpas C; Sharmin S; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Trojano M; Grammond P; Lugaresi A; Onofrj M; Ozakbas S; Butzkueven H; Sola P; Ferraro D; Alroughani R; Grand'Maison F; Terzi M; Lechner-Scott J; Boz C; Hupperts R; Shaygannejad V; Bergamaschi R; Pucci E; Van Pesch V; Hodgkinson S; McCombe P; Granella F; Slee M; Van Wijmeersch B; Karabudak R; Prevost J; Petersen T; Spitaleri D; Barnett M; Solaro C; Iuliano G; Verheul F; Ramo-Tello C; Turkoglu R; Fernandez Bolanos R; Butler E; Macdonell R; Soysal A; Betancur MM; Kalincik T, 2018, 'Determinants of MS re-activation after discontinuing therapies', presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), GERMANY, Berlin, 10 October 2018 - 12 October 2018

Ledingham D; El-Wahsh S; Cappelen-Smith C; Hodgkinson S; McDougall A; Maley M; Cordato D, 2018, 'PARADOXICAL REACTION IN TUBERCULOUS MENINGITIS: A TERTIARY REFERRAL HOSPITAL RETROSPECTIVE EXPERIENCE OF CONCOMITANT IMMUNOSUPPRESSION THERAPY', presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Darwin, 29 May 2018 - 01 June 2018, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.17

Conference Abstracts

Haile DC; Diouf I; Ozakbas S; Horakova D; Havrdova EK; Patti F; Eichau S; Alroughani R; Lugaresi A; Tomassini V; Prat A; Girard M; Terzi M; Yamout B; Khoury SJ; Grammond P; Blanco Y; Shaygannejad V; Foschi M; Surcinelli A; Neri S; Weinstock-Guttman B; Prevost J; Amato MP; Barnett M; Gerlach O; John N; Kermode AG; Fabis-Pedrini M; Carroll WM; van der Walt A; Butzkueven H; van Pesch V; Soysal A; Gouider R; Mrabet S; Spitaleri D; Cartechini E; Maimone D; Ampapa R; Laureys G; Ramo-Tello C; Di Gregorio M; Lapointe E; Slee M; Karabudak R; Garber J; Altintas A; Hodgkinson S; Sanchez-Menoyo JL; Castillo-Triviño T; Habek M; Al-Asmi A; Al-Harbi T; Csepany T; Cárdenas-Robledo S; Taylor B; Foong YC; Willekens B; Shalaby N; Moore F; McGuigan C; Baghbanian SM; Massey J; Hardy TA; Ramanathan S; Gross-Paju K; Gray O; Decoo D; Shaw C; Simu M; Rozsa C; Stuart EA; Sharmin S; Roos I; Kalincik T, 2026, 'Causal effects of multiple sclerosis therapies in left-truncated registry data', in Multiple Sclerosis Journal, Vol. 32, pp. 1052 - 1068, http://dx.doi.org/10.1177/13524585261459943

Hall BM; Verma ND; Rakesh P; Al-atiyah R; Tran GT; Carter N; Hodgkinson SJ, 2026, 'P1.142: Activation of antigen specific CD4+CD25+Foxp3+T regulatory cells that mediate antigen specific regulation from non-antigen specific Treg.', in Transplantation, Wolters Kluwer, Vol. 110, http://dx.doi.org/10.1097/01.tp.0001252704.36410.fd

Al-atiyah R; Verma ND; Carter N; Tran GT; Hodgkinson SJ; Hall BM, 2026, 'P1.143: Changes in Treg subpopulations and cytokine receptor expression in human CD4+CD25+CD127lo Treg upon activation with alloantigen and rIL-2.', in Transplantation, Wolters Kluwer, Vol. 110, http://dx.doi.org/10.1097/01.tp.0001252708.19907.68

Al-atiyah R; Verma N; Kawalia P; Tran G; Hodgkinson S; Hall B, 2024, 'Activation of human CD4+CD25+CD127lo Treg with alloantigen and rIL-2 induces IFNGR', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065872.18320.b6

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, 'B cell phenotypes in peripheral blood of patients with renal allograft.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065376.80110.31

Verma N; Kawalia P; Al-atiyah R; Tran G; Rakesh P; Carter N; Hodgkinson S; Bruce H, 2024, 'Human CD4+CD25+CD127lo Treg can be activated in vitro with alloantigen and rIL-4 to induce receptor for interleukin 5 (IL-5Ra).', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065108.83650.af

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, 'T regulatory cell phenotypes in renal transplant patients with long surviving graft, increased Th2-like Treg and reduced Th1-and Th17-like Treg.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065100.92615.5f

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-Atiyah R; Suranyi M; Spicer T; Wong J; Hodgkinson SJ; Hall BM; Verma ND, 2024, 'Examination of subsets of CD4+lymphocyte subpopulations in long-surviving renal transplant patients', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, SWEDEN, Stockholm, Vol. 39, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024, http://dx.doi.org/10.1093/ndt/gfae069.1666

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-Atiyah R; Suranyi M; Spicer T; Wong J; Hodgkinson SJ; Hall BM; Verma ND, 2024, 'Monitoring of peripheral blood B cell subsets in long-surviving renal transplant patients', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, SWEDEN, Stockholm, Vol. 39, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024, http://dx.doi.org/10.1093/ndt/gfae069.952

Harding-Forrester S; Roos I; Nguyen AL; Malpas CB; Diouf I; Moradi N; Sharmin S; Izquierdo G; Eichau S; Patti F; Horakova D; Kubala Havrdova E; Prat A; Girard M; Duquette P; Grand'Maison F; Onofrj M; Lugaresi A; Grammond P; Ozakbas, S; Amato MP; Gerlach O; Sola P; Ferraro D; Buzzard K; Skibina O; Lechner-Scott J; Alroughani R; Boz C; Van Pesch V; Cartechini E; Terzi M; Maimone D; Ramo-Tello C; Yamout B; Khoury SJ; La Spitaleri D; Sa MJ; Blanco Y; Granella F; Slee M; Butler E; Sidhom Y; Gouider R; Bergamaschi R; Karabudak R; Ampapa R; Sánchez-Menoyo JL; Prevost J; Castillo-Trivino T; McCombe PA; Macdonell R; Laureys G; Van Hijfte L; Oh J; Altintas A; De Gans K; Turkoglu R; Van Der Walt A; Butzkueven H; Vucic S; Barnett M; Cristiano E; Hodgkinson S; Iuliano G; Kappos L; Kuhle J; Shaygannejad V; Soysal A; Weinstock-Guttman B; Van Wijmeersch B; Kalincik T, 2023, 'Disability accrual in primary and secondary progressive multiple sclerosis', in Journal of Neurology Neurosurgery and Psychiatry, Vol. 94, pp. 707 - 717, http://dx.doi.org/10.1136/jnnp-2022-330726

Butzkueven H; Spelman T; Hodgkinson S; Madueño SE; Izquierdo G; Buzzard K; Skibina O; Van Der Walt A; Kalincik T; Grand-Maison F, 2022, 'Real-World Experience with Cladribine in the MSBase Registry', in Multiple Sclerosis and Related Disorders, Elsevier, Vol. 59, pp. 103619, http://dx.doi.org/10.1016/j.msard.2022.103619

Butzkueven H; Spelman T; Ozakbas S; Kalincik T; Boz C; Buzzard K; Skibina O; Alroughani R; Karabudak R; Van der Walt A; Lechner-Scott J; Hodgkinson S; Laureys G; Van Hijfte L; Terzi M; Butler E; Macdonell R; Patti F; Van Pesch V; Slee M; Barnett M; Grammond P; Prevost J; Grand-Maison F; Taylor B; Kermode A; Mccombe P; Duquette P; Prat A; Girard M; Eichau Madueno S; Izquierdo G; Soysal A; Sanchez-Menoyo JL; Sotoca J; Muros-Le Rouzic E; Dirks P, 2020, 'Real-world experience with ocrelizumab in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 550 - 551, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020

Pender MP; Hodgkinson SJ; Broadley S; Lindsey J; Ioannides ZA; Bagert B; Khanna R; Smith C; Gamelin L; Ye W; Willmer J; Bar-Or A, 2020, 'Phase i study of ata188, an off-the-shelf, allogeneic epstein-barr virus-targeted t-cell immunotherapy for progressive forms of multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 228 - 228, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100451&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jokubaitis V; Yeh W; Widyastuti P; Stankovich J; Gresle M; Havrdova EK; Horakova D; Vodehnalova K; Ozakbas S; Madueno SE; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Van der Walt A, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of postpartum relapse and disability progression', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 652 - 653, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547102220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Neill D; Sharma M; Gonzales B; Vandenheuval M; Tse B; Hodgkinson S, 2020, 'Switching from ocrelizumab to cladribine: real world data', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 67 - 68, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma N; O'Neill D; Al-Atiyah R; Sharma M; Tran G; Hall B; Hodgkinson S, 2020, 'The effect of cladribine upon naive and activated cd4(+) t regulatory cells in ms patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 314 - 314, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101180&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Maltby V; Lydon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T; Lechner-Scott J, 2020, 'Cladribine: a multicentre LOng-term efficacy Biomarker Australian Study (CLOBAS)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharmin S; Bovis F; Malpas C; Horakova D; Havrdova E; Ayuso GI; Eichau S; Trojano M; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Ferraro D; Terzi M; Hupperts RMM; Alroughani R; Boz C; Shaygannejad V; Van Pesch V; Kappos L; Lechner-Scott J; Bergamaschi R; Turkoglu R; Solaro C; Ramo-Tello C; Iuliano G; Granella F; Van Wijmeersch B; Spitaleri DLA; Fernandez Bolanos R; Slee M; McCombe P; Prevost J; Ampapa R; Ozakbas S; Luis Sanchez-Menoyo J; Soysal A; Vucic OS; Petersen T; Verheul F; Butler E; Hodgkinson S; Sidhom Y; Gouider R; Cristiano E; Olascoaga Urtaza FJ; Laura Saladino M; Barnett M; Deri N; Moore F; Rozsa C; Yamout B; Skibina O; Gray O; Campbell J; Sempere A; Singhal B; Fragoso Y; Shaw C; Kermode A; Petkovska-Boskova T; Taylor B; Simo M; Vella N; Shuey N; Alkhaboori J; Al-Harbi T; Macdonell R; Andres Dominguez J; Kister I; Csepany T; Vrech C; Kovacs K; Adella Sirbu C; Hughes S; Sormani MP; Butzkueven H; Kalincik T, 2020, 'Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058004051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Neill D; Hodgkinson S, 2020, 'Short term efficacy and safety outcomes after switching from Anti-CD20 DMTs to Cladribine in a real-world setting', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

L-Scott J; Maltby V; Lydon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T, 2019, 'Cladribine: a multicentre Long-term efficacy Biomarker Australian Study (CLOBAS)', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP63, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson S; Lizak N; Butler E; Lechner-Scott J; Slee M; McCombe P; Shaw C; Skibina O; Vucic S; Shuey N; Barnett M; Parratt J; Butzkueven H; Jack D; Fabris J; Kalincik T; Jokubaitis VG, 2019, 'Clinical experience with cladribine in patients with relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP64 - NP65, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson S; Butzkueven H; Spelman T; Patti F; Eichau S; Grand'Maison F; Kalincik T; Skibina O; Butler E, 2019, 'Real world experience with Cladribine (Mavenclad) in MSBase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP64, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma ND; Chiu C; Lam A; Sharma M; Baker S; Limbu B; Robinson C; Tran G; Hall BM; Hodgkinson SJ, 2019, 'Multiple sclerosis associated with increased activated CD4+CD25+Foxp3+T regulatory cells but reduced Th17 associated regulatory cells', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, Vol. 25, pp. 918 - 918, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019

Valente M; Cappelen-Smith C; Mcdougall A; Hodgkinson S; Thomas P; Cordato D, 2019, '"Code stroke" in the 24-hour time window from stroke onset: burden on hospital resources', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 14, pp. 9 - 9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485243200034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhaskar S; Saab J; Cappelen-Smith C; Cordato D; Cheung A; Manning N; Wenderoth J; Thomas P; Aouad P; Beran R; Hodgkinson S; McDougall A; Killingsworth M, 2019, 'Cryptogenic stroke is linked to cardioembolic aetiology: a histopathological study of thrombus retrieved after endovascular thrombectomy', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 20 - 20, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019

Bhaskar S; Saab J; Cappelen-Smith C; Cordato D; Cheung A; Manning N; Wenderoth J; Thomas P; Calic Z; Firtko A; Beran R; Hodgkinson S; McDougall A; Killingsworth M, 2019, 'Erythrocyte-rich clots are associated with cardioembolic aetiology, reduced number of manoeuvres, and improved clinical outcome in acute ischemic stroke patients', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 180 - 180, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474481000283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lechner-Scott J; Maltby V; Lyndon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T, 2019, 'CLADRIBINE: A MULTICENTRE LONG-TERM EFFICACY BIOMARKER AUSTRALIAN STUDY (CLOBAS)', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Sydney, Vol. 90, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Sydney, 21 May 2019 - 24 May 2019, http://dx.doi.org/10.1136/jnnp-2019-anzan.119

Hall BM; Tran G; Verma ND; Robinson CM; Wilcox P; Hodgkinson SJ, 2019, 'Activation of naive CD4(+)CD25(+)FOXP3(+)Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500434&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall BM; Verma ND; Robinson CM; Wang C; Sharland A; Tran G; Wilcox P; Hodgkinson SJ, 2019, 'Recently alloactivated CD4(+)CD8(-)CD25(+)T regulatory cells express CD8alpha and are potent suppressor cells', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall BM; Tran G; Verma ND; Robinson CM; Wilcox P; Hodgkinson SJ, 2019, 'Activation of naive CD4+CD25+FOXP3+Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in The Journal of Immunology, Oxford University Press (OUP), Vol. 202, pp. 116.16 - 116.16, http://dx.doi.org/10.4049/jimmunol.202.supp.116.16

Hall BM; Verma ND; Robinson CM; Wang C; Sharland A; Tran G; Wilcox P; Hodgkinson SJ, 2019, 'Recently alloactivated CD4+CD8−CD25+T regulatory cells express CD8alpha and are potent suppressor cells', in The Journal of Immunology, Oxford University Press (OUP), Vol. 202, pp. 57.20 - 57.20, http://dx.doi.org/10.4049/jimmunol.202.supp.57.20

Hall BM; Rakesh P; Tran G; Hall R; Bedi S; Robinson CM; Sharland A; Wang C; Hodgkinson SJ; Verma ND, 2019, 'Th2 cytokines and specific donor alloantigen activated CD4+CD25+T cells reverse chronic rejection: role of IL-4 and IL-5 in promoting antigen-specific Treg', in The Journal of Immunology, Oxford University Press (OUP), Vol. 202, pp. 186.11 - 186.11, http://dx.doi.org/10.4049/jimmunol.202.supp.186.11

Desai M; Alsahli K; Cheung A; Wenderoth J; Kohli A; Cappelen-Smith C; Cordato D; Tay K; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2019, 'Non-Contrast Computed Tomography Based Patient Selection Achieves Similar Outcomes to Advanced Neuroimaging in Late Time Window Endovascular Thrombectomy', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, HI, Honolulu, Vol. 50, presented at American-Heart-Association/American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium, HI, Honolulu, 06 February 2019 - 08 February 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478733400150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhaskar S; Thomas P; Cappelen-Smith C; McDougall A; Hodgkinson S; Cordato D, 2018, 'Factors associated with delayed hospital presentation for acute stroke events in South Western Sydney', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 13, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440952200111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma N; Lam A; Chiu C; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM, 2018, 'Alloactivation of Human CD4+CD25+CD127loCD45RA-Fox3hi Treg Population to Induce Potential Alloantigen Specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, SPAIN, Madrid, Vol. 102, pp. S145 - S145, presented at 27th International Congress of the Transplantation-Society (TTS), SPAIN, Madrid, 30 June 2018 - 05 July 2018, http://dx.doi.org/10.1097/01.tp.0000542769.25232.5b

Chiu CHY; Lam AD; Verma ND; Tran GT; Robinson CM; Hall BM; Hodgkinson SJ, 2018, 'Activation of Human Naive T Regulatory Cells for MS Therapy By Stimulation with Antigen and Interleukin-4', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 89 - 89, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lam AD; Chiu CHY; Verma ND; Robinson CM; Tran GT; Hall BM; Hodgkinson SJ, 2018, 'Phenotypic Analysis of T Regulatory Cells in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 93 - 94, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Trewin BP; Tilling J; Levy S; Hodgkinson SJ, 2018, 'Response to Immunosuppressive Therapy in Cerebral Amyloid Angiopathy-related Inflammation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Sydney, Vol. 25, pp. 492 - 492, presented at Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), AUSTRALIA, Sydney, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460691800161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM, 2017, 'Human CD4+CD25+CD127loFOXP3+Treg Activation by IL-4 and Alloantigen Induces Activated Treg that do not Express CD45RA and Express the IL-5 Receptor Alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S7 - S7, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520300.20897.2c

Wilcox P; Robinson CM; Verma ND; Nomura M; Tran GT; Carter N; Boyd R; Hodgkinson SJ; Hall BM, 2017, 'CD8 Expression Increases Suppressive Ability of CD4+CD25+Treg and is a Marker of Antigen-Specificity', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S37 - S37, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520351.47820.c8

Hall BM; Hall RM; Verma ND; Robinson CM; Wilcox P; Tran GT; Wang C; Sharland A; Hodgkinson SJ, 2017, 'Interleukin 5 (IL-5) Treatment Prevents Chronic Allograft Rejection by Promoting IL-5 Receptor Expressing CD4+CD25+T Regulatory Ts2 Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S43 - S43, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520363.08810.76

Merkel B; Jokubaitis V; Spelman T; Lechner-Scott J; McCombe P; Slee M; Vucic S; Skibina O; Barnett M; Hodgkinson S; Butzkueven H; Kalincik T, 2017, 'TIMING OF HIGH-EFFICACY DISEASE MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.16

Stewart T; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Duquette P; Girard M; Prat A; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Shaygannejad V; Hupperts R; Alroughani R; Oreja-Guevara C; Pucci E; Boz C; Lechner-Scott J; Bergamaschi R; Van Pesch V; Iuliano G; Ramo C; Taylor B; Slee M; Spitaleri D; Granella F; Verheul F; McCombe P; Hodgkinson S; Amato MP; Vucic S; Gray O; Cristiano E; Barnett M; Sanchez Menoyo JL; Van Munster E; Saladino ML; Olascoaga J; Prevost J; Deri N; Shaw C; Singhal B; Moore F; Rozsa C; Shuey N; Skibina O; Kister I; Petkovska-Boskova T; Ampapa R; Kermode A; Butzkueven H; Jokubaitis V; Kalincik T, 2017, 'Contribution of different relapse phenotypes to disability in multiple sclerosis', in Multiple Sclerosis, Vol. 23, pp. 266 - 276, http://dx.doi.org/10.1177/1352458516643392

Back to profile page